Роль стволовых клеток в лечении недержания мочи: обзор литературы

Автор: Ниткин Д.М., Гресь А.А., Кветень А.Г.

Журнал: Экспериментальная и клиническая урология @ecuro

Статья в выпуске: 3, 2018 года.

Бесплатный доступ

Недержание мочи - распространенное урологическое заболевание. Выполнен обзор клинических исследований с целью систематизации накопленного мирового опыта применения стволовых клеток (СК) в лечении недержания мочи. Проанализированы различные источники получения СК (костный мозг, мышечная и жировая ткань), пути и методы введения при лечении недержания мочи как у мужчин, так и у женщин, представлены методы оценки отдаленных результатов процедуры. Среди существующих методик наиболее приемлемое для стрессового недержания мочи - трансуретральное введение СК

Стволовые клетки, недержание мочи, ургентное недержание мочи, стрессовое недержание мочи, недостаточность уретрального сфинктера

Короткий адрес: https://sciup.org/142216894

IDR: 142216894

Список литературы Роль стволовых клеток в лечении недержания мочи: обзор литературы

Norton P, Brubaker L. Urinary incontinence in women. Lancet 2006;Jan7;367(9504):57-67 DOI: 10.1016/S0140-6736(06)67925-7
Hunskaar S, Lose G, Sykes D, Voss S. tte prevalence of urinary incontinence in women in four European countries. BJU Int 2004;93(3):324-330. PMID: 14764130
Gerullis H, Eimer C, Georgas E, Homburger M, El-Baz AG, Wishahi M и соавт. Muscle-derived cells for treatment of iatrogenic sphincter damage and urinary incontinence in men. Scientific World Journal 2012;2012:898535 DOI: 10.1100/2012/898535
Ниткин Д.М., Куликов А.А. Стрессовое недержание мочи у женщин: учеб. -метод. Пособие. Минск, БелМАПО, 2016 -39 с. ISBN 978-985-584-026-9
Вощула В.И., Ниткин Д.М. и др. Недержание мочи у женщин: этиопатогенез, диагностика, лечение: учеб. Метод. Пособие, Минск, БелМАПО, 2010.-29с. ISBN 978-985-499-393-5
Bozkurt A, Akin Y, Nuhoglu B. Post Prostatectomy Incontinence. JAREM 2012;2:96-100 DOI: 10.5152/jarem.2012.23
Kim JC, Cho KJ. Current Trends in the Management of Post-Prostatectomy Incontinence. Korean J Urol 2012;Aug;53(8):511-518 DOI: 10.4111/kju.2012.53.8.511
Chapple CR, Wein AJ, Brubaker L, Dmochowski R, Pons ME, Haab F и соавт. Stress incontinence injection therapy: what is best for our patients? Eur Urol 2005;Oct;48(4):552-565. doi: 10.1016/j.eururo.2005.06.012
Kuismanen K, Sartoneva R, Haimi S, Mannerstrom B, Tomas E, Miettinen S и соавт. Autologous adipose stem cells in treatment of female stress urinary incontinence: results of a pilot study. Stem Cells Transl Med 2014;3(8):936-941 DOI: 10.5966/sctm.2013-0197
Yamamoto T, Gotoh M, Kato M, Majima T, Toriyama K, Kamei Y, et al. Periurethral injection of autologous adipose-derived regenerative cells for the treatment of male stress urinary incontinence: Report of three initial cases. Int J Urol 2012;19(7):652-659 DOI: 10.1111/j.1442-2042.2012.02999.x
Singla N, Singla AK. Post-prostatectomy incontinence: Etiology, evaluation, and management. Turk J Urol 2014;40(1):1-8. d oi: 10.5152/tud.2014.222014
Hakim L, Endo M, Feola A, Soebadi DM, Deprest J, De Ridder D и соавт. High-fFrequency micro-ultrasound: a novel method to assess external urethral sphincter function in rats following simulated birth injury. Neurourol Urodyn 2015;34(3):264-269 DOI: 10.1002/nau.22555
Williams JK, Dean A, Badlani G, Andersson KE. Regenerative Medicine Therapies for Stress Urinary Incontinence J Urol 2016;196(6): 1619-1626 DOI: 10.1016/j.juro.2016.05.136
Turco MP, de Souza AB, de Campos Sousa I, Fratini P, Veras MM, Rodrigues MN, et al. Periurethral muscle-derived mononuclear cell injection improves urethral sphincter restoration in rats. Neurourol Urodyn 2017;36(8):2011-2018 DOI: 10.1002/nau.23262
Kantartzis KL, Moalli PA. Stem Cell tterapy for Female Urinary Incontinence. Curr Obstet Gynecol Rep 2013;2(3):123-128. doi.org/10.1007/s13669-013-0049-4.
Сергеев В.С. Иммунологические свойства стромальных (мезенхимальных) стволовых клеток. Клеточные технологии 2005(04)
Lee JY, Cannon TW, Pruchnic R, Fraser MO, Huard J, Chancellor MB. tte effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2003;14(1):31-37 DOI: 10.1007/s00192-002-1004-5
Mitterberger M, Marksteiner R, Margreiter E, Pinggera GM, Colleselli D, Frauscher F и соавт. Autologous myoblasts and fi-broblasts for female stress incontinence: a 1-year follow-up in 123 patients. BJU Int 2007;100(5):1081-1085 DOI: 10.1111/j.1464-410X.2007.07119.x
Mitterberger M, Marksteiner R, Margreiter E, Pinggera GM, Frauscher F, Ulmer H et al. Myoblast and fibroblast therapy for postprostatectomy urinary incontinence: 1-year followup of 63 patients. J Urol 2008;179(1):226-231 DOI: 10.1016/j.juro.2007.08.154
Mitterberger M, Pinggera GM, Marksteiner R, Margreiter E, Fussenegger M, Frauscher F et al. Adult stem cell therapy of female stress urinary incontinence. Eur Urol 2008;53(1):169-175 DOI: 10.1016/j.eururo.2007.07.026
Carr LK, Steele D, Steele S, Wagner D, Pruchnic R, Jankowski R et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008;Jun;19(6):881-883 DOI: 10.1007/s00192-007-0553-z
Lee CN, Jang JB, Kim JY, Koh C, Baek JY, Lee KJ. Human cord blood stem cell therapy for treatment of stress urinary incontinence. J Korean Med Sci 2010;Jun;25(6):813-816 DOI: 10.3346/jkms.2010.25.6.813
Sebe P., Doucet C, Cornu JN, Ciofu C, Costa P, de Medina SG et al. Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study. Int Urogynecol J 2011;Feb;22(2):183-189. doi: 10.1007/s00192-010-1255-5
Blaganje M, Lukanovic A. Intrasphincteric autologous myoblast injections with electrical stimulation for stress urinary incontinence. Int J Gynaecol Obstet 2012;May;117(2):164-167. doi: 10.1016/j.ijgo.2011.11.029
Shirvan MK, Alamdari DH, Mahboub MD, Ghanadi A, Rahimi HR, Seifalian AM. A novel cell therapy for stress urinary incontinence, short-term outcome. Neurourol Urodyn 2013;Apr;32(4):377-382 DOI: 10.1002/nau.22301
Carr LK, Robert M, Kultgen PL, Herschorn S, Birch C, Murphy M и соавт. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study. J Urol 2013; Feb;189(2):595-601 DOI: 10.1016/j.juro.2012.09.028
Stangel-Wojcikiewicz K, Jarocha D, Piwowar M, Jach R, Uhl T, Basta A и соавт. Autologous muscle-derived cells for the treatment of female stress urinary incontinence: a 2-year follow-up of a Polish investigation. Neurourol Urodyn 2014;Mar;33(3):324-330 DOI: 10.1002/nau.22404
Gotoh M, Yamamoto T, Kato M, Majima T, Toriyama K, Kamei Y и соавт. Regenerative treatment of male stress urinary incontinence by periurethral injection of autologous adipose-derived regenerative cells: 1-year outcomes in 11 patients. Int J Urol 2014;Mar;21(3):294-300 DOI: 10.1111/iju.12266
Cornu JN, Lizee D, Pinset C, Haab F. Long-term follow-up after regenerative therapy of the urethral sphincter for female stress urinary incontinence. Eur Urol 2014;Jan;65(1):256-258. doi: 10.1016/j.eururo.2013.09.022
Peters KM, Dmochowski RR, Carr LK, Robert M, Kaufman MR, Sirls LT и соавт. Autologous muscle derived cells for treatment of stress urinary incontinence in women. J Urol 2014;Aug;192(2):469-476 DOI: 10.1016/j.juro.2014.02.047
Choi JY, Kim TH, Yang JD, Suh JS, Kwon TG. Adipose-Derived Regenerative Cell Injection Therapy for Postprostatectomy Incontinence: A Phase I Clinical Study. Yonsei Med J 2016;Sep;57(5):1152-1158 DOI: 10.3349/ymj.2016.57.5.1152
Stangel-Wojcikiewicz K, Piwowar M, Jach R, Majka M, Basta A. Quality of life assessment in female patients 2 and 4 years after muscle-derived cell transplants for stress urinary incontinence treatment. Ginekol Pol 2016;87:183-189 DOI: 10.17772/gp/61330
Шкарупа Д.Д., Кубин Н.Д., Пешков Н.О., Комяков Б.К., Писарев А.В., Зайцева А.О. Русскоязычные версии опросников для оценки качества жизни больных с пролапсом тазовых органов и стрессовым недержанием мочи. Экспериментальная и клиническая урология. 2016(1):94-97
Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, at al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 2010;29(1):213-240 DOI: 10.1002/nau.20870
EAU Guidelines on Urinary Incontinence 2017. ISBN 978-90-79754-91-5
Turco MP, de Souza AB, de Campos Sousa I, Fratini P, Veras MM, Rodrigues MN et al. Periurethral muscle-derived mononuclear cell injection improves urethral sphincter restoration in rats. Neurourol Urodyn 2017;Nov;36(8):2011-2018 DOI: 10.1002/nau.23262
Tran C, Damaser MS. The potential role of stem cells in the treatment of urinary incontinence. Ther Adv Urol 2015;Feb;7(1):22-40 DOI: 10.1177/1756287214553968
Lee HJ, Won JH, Doo SH, Kim JH, Song KY, Lee SJ, et al. Inhibition of collagen deposit in obstructed rat bladder outlet by transplantation of superparamagnetic iron oxide-labeled human mesenchymal stem cells as monitored by molecular magnetic resonance imaging (MRI). Cell Transplant 2012;21(5):959-970 DOI: 10.3727/096368911X627516
Zhang H, Qiu X, Shindel AW, Ning H, Ferretti L, Jin X, еt al. Adipose tissue-derived stem cells ameliorate diabetic bladder dysfunction in a type II diabetic rat model. Stem Cells Dev 2012;Jun10;21(9):1391-1400 DOI: 10.1089/scd.2011.0244

Еще

Статья научная